Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar stockgripes (98.50) Submitted: 4/8/2010 11:53:33 AM : Underperform Start Price: $4.30 TCM Score: +8.40

must be kidding?

Featured Broker Partners


Advertisement